__timestamp | Rhythm Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 1213000 | 24518692 |
Thursday, January 1, 2015 | 3425000 | 19886580 |
Friday, January 1, 2016 | 6311000 | 12631689 |
Sunday, January 1, 2017 | 9518000 | 21977998 |
Monday, January 1, 2018 | 28080000 | 20759000 |
Tuesday, January 1, 2019 | 36550000 | 20838000 |
Wednesday, January 1, 2020 | 46125000 | 121812000 |
Friday, January 1, 2021 | 68486000 | 152137000 |
Saturday, January 1, 2022 | 92032000 | 83231000 |
Sunday, January 1, 2023 | 117532000 | 122706000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, TG Therapeutics saw a significant increase in SG&A expenses, peaking in 2021 with a 540% rise from 2014. Meanwhile, Rhythm Pharmaceuticals experienced a staggering 9,600% increase in the same period, highlighting its aggressive expansion strategy.
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Rhythm Pharmaceuticals, Inc.
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Teva Pharmaceutical Industries Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared